FMP

FMP

Blogs by Tony Dante

Jul 25, 2025 9:04 AM - Tony Dante

Phillips 66 (NYSE:PSX) Surpasses Earnings Expectations

Phillips 66 (NYSE:PSX) is a diversified energy manufacturing and logistics company. It operates in four segments: Midstream, Chemicals, Refining, and Marketing and Specialties. The company is a major player in the oil and gas industry, competing with other giants like ExxonMobil and Chevron. Phillip...

blog post title

Jul 25, 2025 7:00 AM - Tony Dante

Phillips 66 (NYSE: PSX) Shows Promising Growth and Dividend Yield

Phillips 66 (NYSE: PSX) is a well-established energy company with a diverse portfolio. It operates in four main segments: Midstream, Chemicals, Refining, and Marketing and Specialties. The company is involved in the transportation and storage of crude oil, production and marketing of chemicals, refi...

blog post title

Jul 25, 2025 2:00 AM - Tony Dante

Western Union (NYSE: WU) Q2 Earnings Preview: A Mixed Financial Picture

Western Union (NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments. The company is set to release its second-quarter earnings on July 28, 2025. Analysts expect an earnings per share (EPS) of $0.44, consistent with the same quarter last year. Revenue is projected ...

blog post title

Jul 24, 2025 8:00 AM - Tony Dante

Charter Communications (NASDAQ:CHTR) Quarterly Earnings Overview

Charter Communications, listed as NASDAQ:CHTR, is a leading broadband connectivity company and cable operator in the United States. It provides services to residential and commercial customers under the Spectrum brand. As a major player in the telecommunications industry, Charter competes with compa...

blog post title

Jul 24, 2025 1:05 AM - Tony Dante

Champions Oncology, Inc. (NASDAQ:CSBR): A Comprehensive Analysis of Its Financial Performance

Champions Oncology, Inc. (NASDAQ:CSBR) is a key player in the field of translational oncology research. The company offers a range of preclinical and clinical research services to biopharmaceutical organizations. With a focus on oncology, CSBR leverages its extensive resources to provide comprehensi...

blog post title

Jul 23, 2025 3:08 PM - Tony Dante

Cathay General Bancorp (NASDAQ:CATY) Financial Overview and Price Target

Cathay General Bancorp (NASDAQ:CATY) is a financial institution with a strong foothold in Asian-American communities. Founded in 1962 and headquartered in Los Angeles, the bank offers a range of services, including loans and deposit accounts, primarily targeting Chinese-American and other minority c...

blog post title

Jul 23, 2025 2:00 PM - Tony Dante

Alfa Laval AB's Financial Performance in Q2 2025

Alfa Laval AB, listed as ALFVY on the OTC market, is a leading global provider of specialized products and engineering solutions. The company focuses on heat transfer, separation, and fluid handling, serving industries such as energy, marine, and food. Despite facing competition from companies like ...

blog post title

Jul 23, 2025 2:00 PM - Tony Dante

Significant Gains in the Stock Market: A Closer Look at Top Performers

The stock market has recently witnessed significant gains among top-performing companies, with notable price changes across various sectors. Abivax S.A. (NASDAQ:ABVX) leads the surge with a remarkable 556.042% increase, reaching $65.6042. This growth is driven by advancements in clinical trials for ...

blog post title

Jul 23, 2025 8:06 AM - Tony Dante

Synchrony Financial (NYSE:SYF) Price Target and Financial Overview

On July 23, 2025, Terry Ma from Barclays set a price target of $80 for Synchrony Financial (NYSE:SYF). At the time, SYF was priced at $70.66, indicating a potential upside of about 13.22%. Synchrony Financial is a consumer financial services company known for its credit card offerings and partnershi...

blog post title

Jul 23, 2025 8:00 AM - Tony Dante

Boston Scientific Corporation's Impressive Q2 2025 Performance

Boston Scientific Corporation (NYSE: BSX) is a leading medical device company known for its innovative solutions in the healthcare sector. The company operates in various segments, including MedSurg and Cardiovascular, providing products that enhance patient care. Boston Scientific competes with oth...

blog post title